Fingerprint
Dive into the research topics of 'Randomized phase II trial of gemcitabine plus TH-302 versus gemcitabine in patients with advanced pancreatic cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Randomized phase II trial of gemcitabine plus TH-302 versus gemcitabine in patients with advanced pancreatic cancer
Mitesh J. Borad, Shantan G. Reddy, Nathan Bahary, Hope E. Uronis, Darren Sigal, Allen L. Cohn, William R. Schelman, Joe Stephenson, E. Gabriela Chiorean, Peter J. Rosen, Brian Ulrich, Tomislav Dragovich, Salvatore A. Del Prete, Mark Rarick, Clarence Eng, Stew Kroll, David P. Ryan
Research output: Contribution to journal › Article › peer-review
115
Scopus
citations